Research in the mechanism of miR-31 found that it could target genes such as ARID1A [33], SATB2 [34], ARID1A [35], HuR [36], BAP1 [37], EZH2 [38], and RASA1 [39], and it could further activate oncogenes and promote tumor cell proliferation, migration and invasive capability in vitro. This evidence concerns the gene EZH2 and neoplasm.